Managing dyslipidemia in HIV/AIDS patients: challenges and solutions

Human immunodeficiency virus (HIV) is a chronic disease associated with dyslipidemia and insulin resistance. In addition, the administration of combination antiretroviral therapy is associated with an increase in the incidence of metabolic risk factors (insulin resistance, lipoatrophy, dyslipidemia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Husain, Nazik Elmalaika OS, Ahmed, Mohamed H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274137/
https://www.ncbi.nlm.nih.gov/pubmed/25565897
http://dx.doi.org/10.2147/HIV.S46028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274137/
https://www.ncbi.nlm.nih.gov/pubmed/25565897
http://dx.doi.org/10.2147/HIV.S46028

Ejemplares similares